INS and type 2 diabetes mellitus: If pancreatic islet GABA concentration changes out of the physiological range or the pulsatile GABA release is disturbed, it may impair proper insulin and glucagon secretion, potentially alter cell fate and eventually contribute to pathogenesis of type 2 diabetes [19,29,30,35].